As states crack down on delta-8 THC production and sales, the market remains curious: Where does this cannabinoid fit into the broader ecosystem of cannabis and hemp? Are there any market opportunities here?
And what about the *next* delta-8?
In this July 27 webinar, hear from Greg Gerdeman, president and CSO of NASHCX, and Justin Walsh, partner at Gleam Law, who will walk you through the scientific and legal ramifications of delta-8. You will learn the context behind this cannabinoid and the opportunities that accompany emerging consumer trends like this one. |
